
Phio Pharmaceuticals Corp.
PHIONasdaqCIK 1533040HealthcareFiscal year ends Dec 31
Reports and events: 316 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-03-2616:38 ET | 10-Q/A | Quarterly report, amendedPeriod 2017-06-30 | 0001193125-18-096008 |
| 2018-03-2616:34 ET | 10-Q/A | Quarterly report, amendedPeriod 2017-03-31 | 0001193125-18-095994 |
| 2018-03-2616:31 ET | 8-K | 4.02 Non-reliance on financial statements | 0001193125-18-095984 |
| 2018-01-2414:31 ET | 8-K | 8.01 Other events | 0001193125-18-018275 |
| 2018-01-0517:21 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-004623 |
| 2017-11-0807:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-336455 |
| 2017-11-0807:01 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001193125-17-336446 |
| 2017-09-1516:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-17-286393 |
| 2017-08-1817:22 ET | S-1 | Registration statement | 0001193125-17-262349 |
| 2017-08-1007:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-253563 |
| 2017-08-1007:06 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001193125-17-253552 |
| 2017-08-0907:38 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-17-252087 |
| 2017-08-0308:06 ET | 8-K | 3.01 Delisting notice | 0001193125-17-246784 |
| 2017-07-3117:29 ET | S-1/A | Registration statement, amended | 0001193125-17-242561 |
| 2017-07-1417:16 ET | S-1 | Registration statement | 0001193125-17-228636 |
| 2017-06-0917:20 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-17-200237 |
| 2017-05-1107:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-166579 |
| 2017-05-1107:01 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001193125-17-166563 |
| 2017-05-0107:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-17-150170 |
| 2017-04-2716:31 ET | DEF 14A | Proxy statementPeriod 2017-06-06 | 0001193125-17-143109 |
| 2017-04-1816:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-17-127431 |
| 2017-03-3007:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-102782 |
| 2017-03-3007:01 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001193125-17-102730 |
| 2017-03-2913:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-17-101354 |
| 2017-03-2811:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-17-099178 |
| 2017-02-0317:25 ET | 8-K | 3.01 Delisting notice | 0001193125-17-030905 |
| 2017-01-1017:21 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-17-006979 |
| 2016-12-2116:35 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-16-800538 |
| 2016-12-1920:57 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-796199 |
| 2016-12-1509:06 ET | S-1/A | Registration statement, amended | 0001193125-16-793785 |
| 2016-12-1413:58 ET | S-1/A | Registration statement, amended | 0001193125-16-792793 |
| 2016-11-3021:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-16-779955 |
| 2016-11-3021:49 ET | S-1/A | Registration statement, amended | 0001193125-16-779953 |
| 2016-11-1421:20 ET | S-1/A | Registration statement, amended | 0001193125-16-766243 |
| 2016-11-1007:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-16-765112 |
| 2016-11-1007:01 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001193125-16-765096 |
| 2016-11-0416:33 ET | DEF 14A | Proxy statementPeriod 2016-12-15 | 0001193125-16-760234 |
| 2016-10-2117:19 ET | S-1 | Registration statement | 0001193125-16-743993 |
| 2016-10-1207:11 ET | 8-K | 8.01 Other events | 0001193125-16-736264 |
| 2016-08-1107:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-16-678589 |
| 2016-08-1107:01 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001193125-16-678578 |
| 2016-05-1207:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-16-588044 |
| 2016-05-1207:01 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001193125-16-588016 |
| 2016-05-0416:30 ET | 8-K | 8.01 Other events | 0001193125-16-577701 |
| 2016-04-1514:25 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-16-542971 |
| 2016-03-3016:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-16-523746 |
| 2016-03-3016:08 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001193125-16-523721 |
| 2016-03-0717:20 ET | DEF 14A | Proxy statementPeriod 2016-04-14 | 0001193125-16-495425 |
| 2015-11-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-15-375658 |
| 2015-11-1216:05 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001193125-15-375630 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 20:44 ET. Listed shows no prices and gives no investment advice.